OPEN END TURBO OPTIONSSCHEIN LONG - QUEST DIAGNOSTICS | Real-time BOERSE MUENCHEN 11:27:11 20/05/2024 BST | ||
| 7.44 EUR | +1.50% |
|
| Current month | +3.24% | ||
| 1 month | +21.16% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about QUEST DIAGNOSTICS INCORPORATED
| Date | Price | Change |
|---|---|---|
| 20/05/24 | 7.44 | +1.50% |
| 17/05/24 | 7.33 | +1.10% |
| 16/05/24 | 7.25 | +2.40% |
| 15/05/24 | 7.08 | +1.87% |
| 14/05/24 | 6.95 | -2.39% |
Real-time BOERSE MUENCHEN
Last update May 20, 2024 at 11:27 am
More quotesStatic data
| Product type | Warrant Knock-Out senza Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | QUEST DIAGNOSTICS INCORPORATED |
| Issuer | Goldman Sachs |
| WKN | GQ7MHC |
| ISIN | DE000GQ7MHC4 |
| Date issued | 17/10/2023 |
| Strike | 64.23 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 5.83 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 7.44 € |
|---|---|
| Lowest since issue | 5.62 € |
| Spread | 0.05 € |
| Spread % | 0.67% |
Company Profile
Quest Diagnostics is the world's leading provider of diagnostics testing and information service for patients and health professionals. Net sales break down by activity as follows:
- testing and diagnostic services (97.3%): routine clinical testing, gene-based testing and advanced diagnostic and anatomica pathology diagnostic services;
- other (2.7%).
Sector
-
Ratings for Quest Diagnostics Incorporated
Trading Rating
Investor Rating
ESG Refinitiv
A-
Consensus: Quest Diagnostics Incorporated
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
144.3
USD
Average target price
146.8
USD
Spread / Average Target
+1.70%
- Stock Market
- Certificates
- Certificat
